Allergan Inc. (AGN) reported first quarter non-GAAP EPS of $0.98 Wednesday morning, compared to the consensus estimate of $0.96. The company expects to report second quarter non-GAAP EPS of $1.18 to $1.20 and between $4.70 and $4.76 for the full year 2013.
Allergan gapped open lower Wednesday and has since steadily declined on above average volume. The stock is now down 4.56 at $108.99 and has fallen to over a one-month low.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.